Gene · 1240
CMKLR1: chemerin chemokine-like receptor 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CMKLR1: chemerin chemokine-like receptor 1. Genes, record 1240. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1240
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q99788 | Chemerin-like receptor 1 | 373 | 4 | Ensembl, GeneID, HGNC |
Source UniProt
Patents67
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 41107 | Q99788 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 41109 | Q99788 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 41111 | Q99788 | Espacenet |
| EP 4656247 A2 | 2025-12-03 | 1 | Q99788 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4347 | Q99788 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 259 | Q99788 | Espacenet |
| JP 2025134864 A | 2025-09-17 | 1 | Q99788 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1035 | Q99788 | Espacenet |
| EP 4606428 A2 | 2025-08-27 | 24 | Q99788 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1035 | Q99788 | Espacenet |
1 to 10 of 67
See all 67 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants830
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CMKLR1 papers | Newest fiscal year |
|---|---|---|---|
| T32AI007290 | Molecular and Cellular Immunobiology | 10 | 2025 |
| R01AI047822 | Intestinal Lymphocyte Trafficking | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 5 | 2025 |
| R35GM128641 | Structure, pharmacology and signaling of G protein-coupled receptors (GPCRs) in inflammation | 4 | 2025 |
| I01BX004115 | New Approaches to Combat CNS Inflammation: Targeting a Metabolic Enzyme in Demyelinating Disease | 3 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 3 | 2025 |
| R01DK095491 | Indole dysbiosis and mucosal inflammation | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| ZIAHL002345 | Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders | 3 | 2025 |
| P30CA014599 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 830Source NIH's project files
See all 830 nih grantsPapers1,391
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemerin - CMKLR1 signaling contributes to immune metabolic dysfunction in salt-sensitive hypertension. | Clin Exp Hypertens | 2026 | 42802577 | PubTator, text mining | PubMed |
| Combining pro-resolving therapy with cyclosporine A restores immune homeostasis and reduces toxicity in autoimmune bone marrow failure. | Cell Rep Med | 2026 | 42785302 | PubTator, text mining | PubMed |
| CXCR4+ circulating tumor cells (CTCs) accumulate in subcutaneous, immune suppressive, CXCL12-loaded-hydrogel. | Mater Today Bio | 2026 | 42733769 | PubTator, text mining | PubMed |
| Characterization of posttranslational modification in metabolic dysfunction-associated steatohepatitis: acetylation, lactylation, and phosphorylation. | J Lipid Res | 2026 | 42537908 | PubTator, text mining | PubMed |
| Protocol for studying Chemerin 15-enhanced microglial phagocytosis in cerebral ischemia-reperfusion injury via the ChemR23/p38 MAPK pathway. | STAR Protoc | 2026 | 42490223 | PubTator, text mining | PubMed |
| Coexpression of GITRL confers resistance to Treg cell-mediated immunosuppression to anti-CD19 CAR-NK cells. | Front Immunol | 2026 | 42488650 | PubTator, text mining | PubMed |
| Chemerin Normal Function and Roles in Metabolic and Nonmetabolic Disorders: An Up-To-Date Comprehensive Review. | Biochem Res Int | 2026 | 42415929 | PubTator, text mining | PubMed |
| Targeted, receptor-mediated delivery of a masked d-amino acid cell-penetrating peptide for cell-specific phototoxicity. | FEBS J | 2026 | 42212778 | PubTator, text mining | PubMed |
| Consistent Metabolomic and Genetic Evidence Supports Acisoga as a Key Contributor to Colorectal Neoplasia Progression. | Cancer Epidemiol Biomarkers Prev | 2026 | 42201318 | PubTator, text mining | PubMed |
| Erratum for the Research Article "The chemerin-CMKLR1 axis limits thermogenesis by controlling a beige adipocyte/IL-33/type 2 innate immunity circuit". | Sci Immunol | 2026 | 42030374 | PubTator, text mining | PubMed |
1 to 10 of 1,391
See all 1,391 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1240
GET https://conductscience.org/api/genes/v1/1240/patents?page=2